Needham Maintains Buy on Enovis, Lowers Price Target to $34

Benzinga Newsdesk www.benzinga.com Negative 66.6%

Neg 66.6% Neu 0% Pos 0%

Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $52 to $34.

Comments

No comments yet. Be the first!